|
- KYMRIAH® (tisagenlecleucel) | Official Patient Website
Find info about KYMRIAH® (tisagenlecleucel) Suspension for IV infusion, the conditions it treats, and Important Safety Info, including Boxed Warning
- KYMRIAH® (tisagenlecleucel) | B-cell ALL Treatment
KYMRIAH® (tisagenlecleucel) is a type of immunotherapy for patients with relapsed or refractory (r r) B-cell ALL Discover how KYMRIAH works, what makes it different from other therapies, and whether it could be right for you
- Pediatric ALL Treatment | KYMRIAH® (tisagenlecleucel)
KYMRIAH® (tisagenlecleucel) is approved to treat children and young adults whose B-cell acute lymphoblastic leukemia (ALL) is refractory or in second or later relapse
- What to Expect With KYMRIAH
You and your treatment team may be considering KYMRIAH® (tisagenlecleucel) Below is a detailed description of each step so you know what to expect with KYMRIAH therapy
- Understanding KYMRIAH
Find out how Kymriah, a type of CART cell therapy, works in patients with relapsed refractory follicular lymphoma See full Prescribing Safety Info, including Boxed WARNING
- Diffuse Large B-cell Lymphoma (DLBCL) Treatment | KYMRIAH
Learn about KYMRIAH, a treatment for patients with relapsed or refractory DLBCL See full Prescribing Safety Info, including Boxed Warning
- Frequently Asked Questions | KYMRIAH® (tisagenlecleucel)
Find frequently asked questions regarding KYMRIAH and the treatment of r r ALL See full Prescribing Safety Information, including Boxed Warning
- KYMRIAH® (tisagenlecleucel) Treatment Center Locator
KYMRIAH® (tisagenlecleucel) is available at select treatment centers across the United States See below to find the KYMRIAH Treatment Center nearest to you See full Prescribing and Safety Information, including Boxed Warning
|
|
|